Cargando…

Hypercortisolism in patients with cholestasis is associated with disease severity

BACKGROUND: Cholestasis might lead to an impairment of adrenal function as suggested by in vitro and in vivo data as well as by clinical findings. Bile acid and adrenal steroid metabolism not only share the receptors farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5), b...

Descripción completa

Detalles Bibliográficos
Autores principales: Theiler-Schwetz, Verena, Schlager, Hansjörg, Obermayer-Pietsch, Barbara, Stojakovic, Tatjana, Fauler, Günter, Fickert, Peter, Zollner, Gernot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650422/
https://www.ncbi.nlm.nih.gov/pubmed/34876016
http://dx.doi.org/10.1186/s12876-021-02045-4
_version_ 1784611197780230144
author Theiler-Schwetz, Verena
Schlager, Hansjörg
Obermayer-Pietsch, Barbara
Stojakovic, Tatjana
Fauler, Günter
Fickert, Peter
Zollner, Gernot
author_facet Theiler-Schwetz, Verena
Schlager, Hansjörg
Obermayer-Pietsch, Barbara
Stojakovic, Tatjana
Fauler, Günter
Fickert, Peter
Zollner, Gernot
author_sort Theiler-Schwetz, Verena
collection PubMed
description BACKGROUND: Cholestasis might lead to an impairment of adrenal function as suggested by in vitro and in vivo data as well as by clinical findings. Bile acid and adrenal steroid metabolism not only share the receptors farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5), but supraphysiological bile acid levels were found to stimulate steroidogenesis independent of FXR and TGR5. Our previous experimental findings revealed that mice fed bile acids or subjected to common bile duct ligation develop hypercortisolemia. We thus aimed to assess adrenal gland function in patients with cholestasis. METHODS: Adrenal gland function was assessed in 36 patients with cholestasis and in 32 patients without cholestasis by measuring total serum cortisol, adrenocorticotropic hormone (ACTH), as well as the increase of cortisol 20 and 30 min after administration of 1 µg of ACTH. Bile acid levels and bile acid pool composition were determined by high-resolution mass spectrometry. RESULTS: Patients with cholestasis per definition had markedly elevated levels of alkaline phosphatase (AP), bilirubin and serum bile acids. Baseline cortisol and maximum cortisol after ACTH stimulation were significantly higher in patients with cholestasis compared to controls. Increase of cortisol after ACTH stimulation and ACTH did not differ. In the cholestasis group, baseline cortisol correlated with bilirubin but not with AP, total serum bile acids and levels of conjugated and unconjugated bile acid species. Patients with duration of cholestasis < 6 months (n = 30) had significantly higher baseline cortisol levels than those with long standing cholestasis (> 6 months), together with higher bilirubin levels. CONCLUSIONS: We find no evidence of adrenal insufficiency in non-cirrhotic patients with cholestasis. In contrast, patients with cholestasis show hypercortisolism associated with disease severity as mirrored by levels of bilirubin. Lack of ACTH increase in cholestasis suggests a direct effect of cholestasis on adrenals and not on the pituitary gland. Further studies are needed to elucidate the mechanism of cortisol elevation in patients with cholestasis and its clinical significance.
format Online
Article
Text
id pubmed-8650422
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86504222021-12-07 Hypercortisolism in patients with cholestasis is associated with disease severity Theiler-Schwetz, Verena Schlager, Hansjörg Obermayer-Pietsch, Barbara Stojakovic, Tatjana Fauler, Günter Fickert, Peter Zollner, Gernot BMC Gastroenterol Research BACKGROUND: Cholestasis might lead to an impairment of adrenal function as suggested by in vitro and in vivo data as well as by clinical findings. Bile acid and adrenal steroid metabolism not only share the receptors farnesoid X receptor (FXR) and the G protein-coupled bile acid receptor 1 (TGR5), but supraphysiological bile acid levels were found to stimulate steroidogenesis independent of FXR and TGR5. Our previous experimental findings revealed that mice fed bile acids or subjected to common bile duct ligation develop hypercortisolemia. We thus aimed to assess adrenal gland function in patients with cholestasis. METHODS: Adrenal gland function was assessed in 36 patients with cholestasis and in 32 patients without cholestasis by measuring total serum cortisol, adrenocorticotropic hormone (ACTH), as well as the increase of cortisol 20 and 30 min after administration of 1 µg of ACTH. Bile acid levels and bile acid pool composition were determined by high-resolution mass spectrometry. RESULTS: Patients with cholestasis per definition had markedly elevated levels of alkaline phosphatase (AP), bilirubin and serum bile acids. Baseline cortisol and maximum cortisol after ACTH stimulation were significantly higher in patients with cholestasis compared to controls. Increase of cortisol after ACTH stimulation and ACTH did not differ. In the cholestasis group, baseline cortisol correlated with bilirubin but not with AP, total serum bile acids and levels of conjugated and unconjugated bile acid species. Patients with duration of cholestasis < 6 months (n = 30) had significantly higher baseline cortisol levels than those with long standing cholestasis (> 6 months), together with higher bilirubin levels. CONCLUSIONS: We find no evidence of adrenal insufficiency in non-cirrhotic patients with cholestasis. In contrast, patients with cholestasis show hypercortisolism associated with disease severity as mirrored by levels of bilirubin. Lack of ACTH increase in cholestasis suggests a direct effect of cholestasis on adrenals and not on the pituitary gland. Further studies are needed to elucidate the mechanism of cortisol elevation in patients with cholestasis and its clinical significance. BioMed Central 2021-12-07 /pmc/articles/PMC8650422/ /pubmed/34876016 http://dx.doi.org/10.1186/s12876-021-02045-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Theiler-Schwetz, Verena
Schlager, Hansjörg
Obermayer-Pietsch, Barbara
Stojakovic, Tatjana
Fauler, Günter
Fickert, Peter
Zollner, Gernot
Hypercortisolism in patients with cholestasis is associated with disease severity
title Hypercortisolism in patients with cholestasis is associated with disease severity
title_full Hypercortisolism in patients with cholestasis is associated with disease severity
title_fullStr Hypercortisolism in patients with cholestasis is associated with disease severity
title_full_unstemmed Hypercortisolism in patients with cholestasis is associated with disease severity
title_short Hypercortisolism in patients with cholestasis is associated with disease severity
title_sort hypercortisolism in patients with cholestasis is associated with disease severity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650422/
https://www.ncbi.nlm.nih.gov/pubmed/34876016
http://dx.doi.org/10.1186/s12876-021-02045-4
work_keys_str_mv AT theilerschwetzverena hypercortisolisminpatientswithcholestasisisassociatedwithdiseaseseverity
AT schlagerhansjorg hypercortisolisminpatientswithcholestasisisassociatedwithdiseaseseverity
AT obermayerpietschbarbara hypercortisolisminpatientswithcholestasisisassociatedwithdiseaseseverity
AT stojakovictatjana hypercortisolisminpatientswithcholestasisisassociatedwithdiseaseseverity
AT faulergunter hypercortisolisminpatientswithcholestasisisassociatedwithdiseaseseverity
AT fickertpeter hypercortisolisminpatientswithcholestasisisassociatedwithdiseaseseverity
AT zollnergernot hypercortisolisminpatientswithcholestasisisassociatedwithdiseaseseverity